News
A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback